BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 15, 2003
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Conforma Therapeutics Corp.

San Diego, Calif.

Technology: Hsp90 inhibitors

Disease focus: Cancer

Clinical status: Preclinical

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >